Original article
Peripheral vasculopathy in Raynaud phenomenon: Vascular disease biomarkers
Vasculopatia periférica no fenómeno de Raynaud: o papel dos biomaracdores
Ivone Silvaa,b,
, Andreia Teixeirac, José Oliveirad, Rui Almeidaa, Carlos Vasconcelosb,e,f
Corresponding author
a Angiology and Vascular Surgery Service, Centro Hospitalar do Porto (CHP), Porto, Portugal
b Clinical Immunology Unit, Centro Hospitalar do Porto (CHP), Porto, Portugal
c CINTESIS – Center for Research in Health Technologies and Information Systems, Porto, Portugal
d Clinical Pathology Department, Centro Hospitalar do Porto (CHP), Porto, Portugal
e Abel Salazar Biomedical Health Institute, Porto, Portugal
f Multidisciplinary Unit for Biomedical Investigation (UMIB), University of Porto, Porto, Portugal
Read
6179
Timeswas read the article
860
Total PDF
5319
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 32 | 4 | 36 |
| 2025 11 | 120 | 29 | 149 |
| 2025 10 | 59 | 8 | 67 |
| 2025 9 | 57 | 13 | 70 |
| 2025 8 | 55 | 8 | 63 |
| 2025 7 | 64 | 2 | 66 |
| 2025 6 | 68 | 2 | 70 |
| 2025 5 | 49 | 3 | 52 |
| 2025 4 | 38 | 0 | 38 |
| 2025 3 | 40 | 6 | 46 |
| 2025 2 | 70 | 4 | 74 |
| 2025 1 | 50 | 1 | 51 |
| 2024 12 | 23 | 1 | 24 |
| 2024 11 | 19 | 1 | 20 |
| 2024 10 | 15 | 0 | 15 |
| 2024 9 | 20 | 1 | 21 |
| 2024 8 | 12 | 3 | 15 |
| 2024 7 | 21 | 4 | 25 |
| 2024 6 | 21 | 1 | 22 |
| 2024 5 | 14 | 3 | 17 |
| 2024 4 | 23 | 4 | 27 |
| 2024 3 | 34 | 2 | 36 |
| 2024 2 | 67 | 5 | 72 |
| 2024 1 | 22 | 4 | 26 |
| 2023 12 | 14 | 8 | 22 |
| 2023 11 | 22 | 4 | 26 |
| 2023 10 | 24 | 5 | 29 |
| 2023 9 | 20 | 3 | 23 |
| 2023 8 | 22 | 4 | 26 |
| 2023 7 | 22 | 5 | 27 |
| 2023 6 | 37 | 2 | 39 |
| 2023 5 | 49 | 3 | 52 |
| 2023 4 | 62 | 3 | 65 |
| 2023 3 | 45 | 1 | 46 |
| 2023 2 | 32 | 3 | 35 |
| 2023 1 | 22 | 1 | 23 |
| 2022 12 | 32 | 7 | 39 |
| 2022 11 | 28 | 7 | 35 |
| 2022 10 | 19 | 8 | 27 |
| 2022 9 | 21 | 8 | 29 |
| 2022 8 | 28 | 5 | 33 |
| 2022 7 | 29 | 8 | 37 |
| 2022 6 | 40 | 7 | 47 |
| 2022 5 | 36 | 8 | 44 |
| 2022 4 | 68 | 9 | 77 |
| 2022 3 | 127 | 21 | 148 |
| 2022 2 | 131 | 12 | 143 |
| 2022 1 | 129 | 7 | 136 |
| 2021 12 | 66 | 13 | 79 |
| 2021 11 | 82 | 9 | 91 |
| 2021 10 | 78 | 12 | 90 |
| 2021 9 | 59 | 14 | 73 |
| 2021 8 | 37 | 4 | 41 |
| 2021 7 | 25 | 8 | 33 |
| 2021 6 | 37 | 12 | 49 |
| 2021 5 | 41 | 6 | 47 |
| 2021 4 | 135 | 22 | 157 |
| 2021 3 | 88 | 10 | 98 |
| 2021 2 | 50 | 8 | 58 |
| 2021 1 | 58 | 7 | 65 |
| 2020 12 | 58 | 10 | 68 |
| 2020 11 | 50 | 7 | 57 |
| 2020 10 | 22 | 4 | 26 |
| 2020 9 | 34 | 11 | 45 |
| 2020 8 | 36 | 8 | 44 |
| 2020 7 | 41 | 3 | 44 |
| 2020 6 | 49 | 11 | 60 |
| 2020 5 | 40 | 10 | 50 |
| 2020 4 | 37 | 6 | 43 |
| 2020 3 | 24 | 2 | 26 |
| 2020 2 | 43 | 3 | 46 |
| 2020 1 | 32 | 5 | 37 |
| 2019 12 | 17 | 3 | 20 |
| 2019 11 | 39 | 4 | 43 |
| 2019 10 | 27 | 5 | 32 |
| 2019 9 | 45 | 4 | 49 |
| 2019 8 | 73 | 7 | 80 |
| 2019 7 | 78 | 7 | 85 |
| 2019 6 | 97 | 7 | 104 |
| 2019 5 | 145 | 1 | 146 |
| 2019 4 | 116 | 16 | 132 |
| 2019 3 | 118 | 2 | 120 |
| 2019 2 | 145 | 4 | 149 |
| 2019 1 | 130 | 0 | 130 |
| 2018 12 | 132 | 5 | 137 |
| 2018 11 | 97 | 3 | 100 |
| 2018 10 | 79 | 4 | 83 |
| 2018 9 | 35 | 5 | 40 |
| 2018 8 | 16 | 6 | 22 |
| 2018 7 | 16 | 5 | 21 |
| 2018 6 | 15 | 6 | 21 |
| 2018 5 | 24 | 7 | 31 |
| 2018 4 | 32 | 8 | 40 |
| 2018 3 | 31 | 10 | 41 |
| 2018 2 | 10 | 6 | 16 |
| 2018 1 | 15 | 4 | 19 |
| 2017 12 | 25 | 14 | 39 |
| 2017 11 | 14 | 5 | 19 |
| 2017 10 | 28 | 10 | 38 |
| 2017 9 | 29 | 12 | 41 |
| 2017 8 | 31 | 6 | 37 |
| 2017 7 | 19 | 17 | 36 |
| 2017 6 | 33 | 12 | 45 |
| 2017 5 | 12 | 6 | 18 |
| 2017 4 | 23 | 10 | 33 |
| 2017 3 | 12 | 3 | 15 |
| 2017 2 | 17 | 7 | 24 |
| 2017 1 | 27 | 6 | 33 |
| 2016 12 | 52 | 29 | 81 |
| 2016 11 | 37 | 23 | 60 |
| 2016 10 | 52 | 31 | 83 |
| 2016 9 | 40 | 20 | 60 |
| 2016 8 | 39 | 23 | 62 |
| 2016 7 | 22 | 34 | 56 |
| 2016 6 | 1 | 0 | 1 |
Show all